Eli Lilly and Co
XETRA:LLY
Eli Lilly and Co
XETRA:LLY
Price:
818.8
EUR
2.83%
Market Closed
Market Cap:
€778.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eli Lilly and Co
XETRA:LLY
|
US |
|
Marfrig Global Foods SA
BOVESPA:MRFG3
|
BR |
|
Morarjee Textiles Ltd
NSE:MORARJEE
|
IN |
|
H
|
Hygieia Group Ltd
HKEX:1650
|
SG |
Multiples-Based Value
The
Multiples-Based Value for
Eli Lilly and Co (LLY)
under the Base Case is
hidden
EUR.
Compared with the current market price of 818.8 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LLY Multiples-Based Value
LOCKED
Multiples Across Competitors
LLY Competitors Multiples
Eli Lilly and Co Competitors
Eli Lilly and Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
XETRA:LLY
|
900.7B EUR | 13.9 | 43.9 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 17 | 7.1 | 8.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.5B EUR | 2.6 | 15.1 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
